Le Lézard
Classified in: Health
Subjects: AWD, WOM

Amendola Communications CEO Jodi Amendola Named One of PR News' Top Women in PR for 2017


SCOTTSDALE, Ariz., Dec. 13, 2017 /PRNewswire/ -- Amendola Communications CEO and co-founder Jodi Amendola has been named to PR News' list of the Top Women in PR for 2017. The prestigious award recognizes women executives who have made bold advances in managing crises, developing brand messages, protecting and building brand reputations, and creating content for digital platforms.

Amendola Communications is a full-service, national public relations, social media and marketing communications firm serving the healthcare, healthcare IT, pharmaceutical and high tech industries. (PRNewsFoto/Amendola Communications) (PRNewsFoto/AMENDOLA COMMUNICATIONS)

To download a photo and bio of Jodi Amendola, click here.

Other honorees include PR executives from the world's biggest public relations agencies, as well as communications leaders at some of the world's best-known companies, including Microsoft, T-Mobile, FedEx, Nissan, General Motors, GE, Southwest Airlines, Bayer and Samsung.

Jodi is an accomplished leader with 25 years of experience in developing, implementing and executing high-impact, integrated business-to-business public relations and marketing campaigns. Beginning in 2003, she pioneered an agency focused squarely on the burgeoning healthcare information technology sector. Over the next decade, Jodi transformed a boutique agency with a handful of small clients into the healthcare IT industry's recognized PR leader?a national, full-service public relations and marketing agency serving dozens of technology innovators ranging from early-stage startups to large public companies.

A hands-on leader, Jodi provides strategic direction and ongoing involvement in all phases of client public relations and marketing programs. She embodies the "client-first" dedication and "get-it-done" attitude that makes Amendola Communications both a fun workplace and a collaborative learning environment. Thanks to Jodi's inspirational leadership and values, clients find that Amendola Communications is more than just an agency, as demonstrated by the partnership mentality and commitment to excellence shared by every member of her team.

"I'm honored to join this remarkable group of accomplished women," said Jodi Amendola. "It's been an amazing PR journey. I am so thankful for the many mentors, clients, business associates, employees and family members who have supported me along the way. I look forward to achieving more milestones and to continuing to help healthcare and healthcare IT companies expand their market dominance and industry thought leadership."

Jodi and the Amendola Communications team are available to discuss your public relations and marketing needs, including media relations, content marketing, branding, digital marketing, search engine marketing, website design and development, and social media. For more information, please visit www.acmarketingpr.com or email [email protected].  

About Amendola Communications
Amendola Communications is an award-winning national public relations, marketing communications, social media and content marketing firm. Named one of the best information technology (IT) PR firms in the nation by PRSourceCode for four years running, Amendola Communications represents some of the best-known brands and groundbreaking startups in the healthcare and healthcare IT industries. The organization's seasoned team of PR and marketing pros delivers strategic guidance and effective solutions to help organizations boost their reputation and drive market share. For more information about the PR industry's "A Team," visit www.acmarketingpr.com and follow Amendola on Twitter and LinkedIn.

Media Contact:
Marcia Rhodes
Amendola Communications
[email protected]
602-793-1561

 

SOURCE Amendola Communications


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: